Literature DB >> 10914959

Bone biopsy results and serum bone turnover parameters in uremic children.

H Ziólkowska1, M Pańiczyk-Tomaszewska, A Debiński, Z Polowiec, A Sawicki, M Sieniawska.   

Abstract

UNLABELLED: The aim of the study was to evaluate the prevalence of renal osteodystrophy types in children undergoing haemodialysis and continuous ambulatory peritoneal dialysis and to assess the usefulness of biochemical parameters in diagnosis of renal osteodystrophy. Bone biopsy and measurements of serum parathormone (iPTH) level, alkaline phosphatase (AP), osteocalcin (OC), procollagen 1C, calcium and phosphorus levels were performed in 51 children aged 11.5 +/- 2.9 y with end-stage renal failure. Renal osteodystrophy (ROD) was diagnosed as follows: adynamic bone disease (ABD) in 14 (27%); normal bone histology (NB) in 19 (37%), osteomalacia (OM) in 1 (2%), mixed lesion (Mix) in 5 (10%) and hyperparathyroidism (HP) in 12 (24%) children. There was no difference in prevalence of ROD types between children on CAPD and HD. We found significant differences in the mean value of iPTH, OC levels and AP activity in HP vs NB and HP vs ABD. The prevalence of ABD was significantly higher in patients with PTH below 50 pg/ml than in patients with PTH above 50 pg/ml (p < 0.05). In 69% of children with NB the iPTH level was between 50 and 150 pg/ml. Most HP cases (75%) were diagnosed in patients with iPTH above 200 pg/ml. A high correlation between BFR and iPTH, BFR and OC, AP levels was found.
CONCLUSION: The biochemical markers of bone turnover have only limited value in the differentiation of renal osteodystrophy types.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10914959

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  17 in total

1.  Bone alkaline phosphatase isoforms in hemodialysis patients with low versus non-low bone turnover: a diagnostic test study.

Authors:  Mathias Haarhaus; Marie-Claude Monier-Faugere; Per Magnusson; Hartmut H Malluche
Journal:  Am J Kidney Dis       Date:  2015-04-02       Impact factor: 8.860

Review 2.  Mineral and bone disorders in children with chronic kidney disease.

Authors:  Claus Peter Schmitt; Otto Mehls
Journal:  Nat Rev Nephrol       Date:  2011-09-27       Impact factor: 28.314

Review 3.  Minimizing bone abnormalities in children with renal failure.

Authors:  Helena Ziólkowska
Journal:  Paediatr Drugs       Date:  2006       Impact factor: 3.022

4.  The novel bone alkaline phosphatase B1x isoform in children with kidney disease.

Authors:  Diana Swolin-Eide; Sverker Hansson; Lasse Larsson; Per Magnusson
Journal:  Pediatr Nephrol       Date:  2006-08-24       Impact factor: 3.714

5.  Clinical practice recommendations for treatment with active vitamin D analogues in children with chronic kidney disease Stages 2-5 and on dialysis.

Authors:  Rukshana Shroff; Mandy Wan; Evi V Nagler; Sevcan Bakkaloglu; Mario Cozzolino; Justine Bacchetta; Alberto Edefonti; Constantinos J Stefanidis; Johan Vande Walle; Gema Ariceta; Günter Klaus; Dieter Haffner; Claus Peter Schmitt
Journal:  Nephrol Dial Transplant       Date:  2017-07-01       Impact factor: 5.992

Review 6.  Searching the optimal PTH target range in children undergoing peritoneal dialysis: new insights from international cohort studies.

Authors:  Dieter Haffner; Franz Schaefer
Journal:  Pediatr Nephrol       Date:  2012-08-15       Impact factor: 3.714

7.  Skeletal effects and growth in children with chronic kidney disease: a 5-year prospective study.

Authors:  Diana Swolin-Eide; Sverker Hansson; Per Magnusson
Journal:  J Bone Miner Metab       Date:  2012-12-10       Impact factor: 2.626

8.  Parathyroid hormone and its fragments in children with chronic renal failure.

Authors:  Simon Waller; Anthony Reynolds; Deborah Ridout; Tom Cantor; Ping Gao; Lesley Rees
Journal:  Pediatr Nephrol       Date:  2003-10-24       Impact factor: 3.714

9.  Bone histomorphometry in children prior to commencing renal replacement therapy.

Authors:  Simon Waller; Rukshana Shroff; Anthony J Freemont; Lesley Rees
Journal:  Pediatr Nephrol       Date:  2008-05-15       Impact factor: 3.714

10.  What parathyroid hormone levels should we aim for in children with stage 5 chronic kidney disease; what is the evidence?

Authors:  Lesley Rees
Journal:  Pediatr Nephrol       Date:  2007-11-28       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.